News & Events

• July 5, 2014
  

  PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force

• January 3, 2014
  

  The Patient-Reported Outcome (PRO) Consortium at the Critical Path Institute (C-Path)

• December 1, 2013
  

  Patient-Reported Outcomes In Clinical Trials Of CKD-Related Therapies: Report Of A Symposium Sponsored By The National Kidney Foundation And The US Food And Drug Administration

• May 28, 2013
  

  Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure

  McCarrier K, Abraham L, Blum S, Bush E, Bushnell D, Carpenter L, Coons S, Houle C, Martin M, Mathews M, Trivedi M, Thase M, on behalf of the PRO Consortium Depression Working Group. Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure. 53rd New Clinical Drug Evaluation Unit (NCDEU): An Annual Meeting Sponsored by the American Society of Clinical Psychopharmacology (ASCP); 2013 May 28; Hollywood, FL, USA.

   

• January 3, 2013
  

  The Patient-Reported Outcome (PRO) Consortium at the Critical Path Institute (C-Path)